Skip to Content
MilliporeSigma
All Photos(1)

Key Documents

792578

Sigma-Aldrich

Methyl 1-Boc-azetidine-3-carboxylate

95%

Synonym(s):

1-tert-Butyl 3-methyl azetidine-1,3-dicarboxylate, 1-Boc-azetidine-3-carboxylic acid methyl ester

Sign Into View Organizational & Contract Pricing


About This Item

Empirical Formula (Hill Notation):
C10H17NO4
CAS Number:
Molecular Weight:
215.25
MDL number:
UNSPSC Code:
12352100
PubChem Substance ID:
NACRES:
NA.22

Pricing and availability is not currently available.

Quality Level

assay

95%

form

liquid

refractive index

n20/D 1.452

density

1.072 g/mL at 25 °C

functional group

ester

SMILES string

CC(C)(C)OC(N(C1)CC1C(OC)=O)=O

InChI

1S/C10H17NO4/c1-10(2,3)15-9(13)11-5-7(6-11)8(12)14-4/h7H,5-6H2,1-4H3

InChI key

SECFRXGVLMVUPD-UHFFFAOYSA-N

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
SAB5701676HPA039481HPA059282
Quality Level

100

Quality Level

100

Quality Level

100

Quality Level

-

conjugate

unconjugated

conjugate

-

conjugate

unconjugated

conjugate

unconjugated

biological source

rabbit

biological source

rabbit

biological source

rabbit

biological source

rabbit

antibody form

affinity isolated antibody

antibody form

-

antibody form

affinity isolated antibody

antibody form

affinity isolated antibody

product line

Prestige Antibodies® Powered by Atlas Antibodies

product line

-

product line

Prestige Antibodies® Powered by Atlas Antibodies

product line

Prestige Antibodies® Powered by Atlas Antibodies

shipped in

wet ice

shipped in

wet ice

shipped in

wet ice

shipped in

wet ice

Application

Building block used as a precursor to the synthesis of azaspiro[3.4]octanes developed in the Carreira group. This substrate can be readily functionalized via enolization at the 3-position in the presence of LDA.

pictograms

Exclamation mark

signalword

Warning

hcodes

Hazard Classifications

Acute Tox. 4 Oral

Storage Class

10 - Combustible liquids

wgk_germany

WGK 3


  • Choose from one of the most recent versions:

    Certificates of Analysis (COA)

    Lot/Batch Number

    Don't see the Right Version?

    If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

    Already Own This Product?

    Find documentation for the products that you have recently purchased in the Document Library.

    Visit the Document Library

    Matthew H Crouthamel et al.
    Arteriosclerosis, thrombosis, and vascular biology, 33(11), 2625-2632 (2013-08-24)
    Elevated serum phosphate has emerged as a major risk factor for vascular calcification. The sodium-dependent phosphate cotransporter, PiT-1, was previously shown to be required for phosphate-induced osteogenic differentiation and calcification of cultured human vascular smooth muscle cells (VSMCs), but its
    Matthew R Weir et al.
    Journal of clinical hypertension (Greenwich, Conn.), 16(12), 875-882 (2014-10-21)
    The effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on blood pressure (BP) and osmotic diuresis- and intravascular volume reduction-related adverse events (AEs) were evaluated using pooled data from four placebo-controlled, phase 3 studies in patients with type 2
    Luciano Candilio et al.
    Heart (British Cardiac Society), 101(3), 185-192 (2014-09-26)
    Remote ischaemic preconditioning (RIPC), using brief cycles of limb ischaemia/reperfusion, is a non-invasive, low-cost intervention that may reduce perioperative myocardial injury (PMI) in patients undergoing cardiac surgery. We investigated whether RIPC can also improve short-term clinical outcomes. One hundred and
    George G S Sandor et al.
    International journal of cardiology, 179, 470-475 (2014-12-04)
    Patients with Marfan (MFS) and Loeys-Dietz (LDS) syndromes have been shown to have abnormal aortic biophysical properties. The purpose of this study was to compare the effects of 12-months of therapy with atenolol or losartan on vascular function in young
    Karen Sliwa et al.
    Heart (British Cardiac Society), 100(24), 1967-1974 (2014-09-18)
    Lack of evidence-based data on the spectrum of cardiovascular disease (CVD) in pregnancy or in the postpartum period, as well as on maternal and fetal outcome, provides challenges for treating physicians, particularly in areas of low resources. The objectives of

    Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

    Contact Technical Service